I agree that this site is using cookies. You can find further informations here.
X
de Kraker, Marlieke E A
123  results:
Search for persons X
?
1

Excess resource use and cost of drug-resistant infections f..:

Kingston, Rhys ; Vella, Venanzio ; Pouwels, Koen B....
Clinical Microbiology and Infection.  30 (2024)  - p. S26-S36 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Synthesizing pathogen- and infection-specific estimates of ..:

Robotham, Julie V. ; Tacconelli, Evelina ; Vella, Venanzio.
Clinical Microbiology and Infection.  30 (2024)  - p. S1-S3 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A systematic review on the excess health risk of antibiotic..:

Hassoun-Kheir, Nasreen ; Guedes, Mariana ; Ngo Nsoga, Marie-Therese...
Clinical Microbiology and Infection.  30 (2024)  - p. S14-S25 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Increased Peripheral Venous Catheter Bloodstream Infections..:

Zanella, Marie-Céline ; Pianca, Eva ; Catho, Gaud...
Emerging Infectious Diseases.  30 (2024)  1 - p. , 2024
Link: https://doi.org/10.3201/..
 
?
5

Antimicrobial resistance in Enterobacterales infections amo..:

Kowalski, Morgane ; Minka Obama, Basilice ; Catho, Gaud...
eClinicalMedicine.  70 (2024)  - p. 102512 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Risk factors for bloodstream infections due to carbapenem-r..:

Zhou, Hongyu ; Buetti, Niccolò ; Pérez-Galera, Salvador...
Journal of Antimicrobial Chemotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
7

The scope of the antimicrobial resistance challenge:

Okeke, Iruka N ; de Kraker, Marlieke E A ; Van Boeckel, Thomas P...
The Lancet.  403 (2024)  10442 - p. 2426-2438 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Attributable mortality of infections caused by carbapenem-r..:

Paniagua-García, María ; Bravo-Ferrer, Jose M. ; Pérez-Galera, Salvador...
Clinical Microbiology and Infection.  30 (2024)  2 - p. 223-230 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Risk factors for infections caused by carbapenem-resistant ..:

Pérez-Galera, Salvador ; Bravo-Ferrer, Jose M. ; Paniagua, María...
eClinicalMedicine.  57 (2023)  - p. 101871 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Mortality associated with third-generation cephalosporin re..:

Aiken, Alexander M ; Rehman, Andrea M ; de Kraker, Marlieke E A...
The Lancet Infectious Diseases.  23 (2023)  11 - p. 1280-1290 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Risk factors for in-hospital mortality and secondary bacter..:

Yi, Guangzhao ; de Kraker, Marlieke E. A. ; Buetti, Niccolò...
Antimicrobial Resistance & Infection Control.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

An obituary on DAV-132—authors' viewpoint on the current li..:

Vehreschild, Maria J G T ; Biehl, Lena M ; Dane, Aaron...
Journal of Antimicrobial Chemotherapy.  78 (2023)  6 - p. 1551-1553 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Understanding the impact of antimicrobial resistance on out..:

de Kraker, Marlieke E. A.
PLOS Medicine.  20 (2023)  7 - p. e1004262 , 2023
Link: https://doi.org/10.1371/..
 
?
14

Hospital outcomes of community-acquired COVID-19 versus inf..:

Fröhlich, Georg Marcus ; De Kraker, Marlieke E. A. ; Abbas, Mohamed...
Eurosurveillance.  27 (2022)  1 - p. , 2022
Link: https://doi.org/10.2807/..
 
?
15

Mortality associated with third-generation cephalosporin re..:

Dramowski, Angela ; Aiken, Alexander M. ; Rehman, Andrea M....
Journal of Global Antimicrobial Resistance.  29 (2022)  - p. 176-184 , 2022
Link: https://doi.org/10.1016/..
 
1-15